Ascendis’ Yuviwel (Navepegritide) Receives the US FDA Accelerated Approval for Achondroplasia
The U.S. FDA granted accelerated approval to Ascendis’ Yuviwel (navepegritide) for increasing linear growth in children aged two years and older with achondroplasia and open epiphyses. Approval rests on three placebo‑controlled trials and up to three years of open‑label extension data, with the pivotal ApproaCH study published in JAMA Pediatrics. Commercial launch in the United States is slated for the second quarter of 2026. The agency also awarded a Rare Pediatric Disease priority review voucher, while requiring confirmatory trials to verify clinical benefit beyond annualized growth velocity.
Why Claims Data Underestimates Mental Health Risk
Employers often rely on isolated claims or EAP call counts, which dramatically understate the true scale of behavioral health issues in the workforce. By aggregating medical, pharmacy, and EAP data—and even website analytics—companies can capture both prevalence and cost, revealing...
NHS Evaluation Shows up to 75% Reduction in Hospital Visits in Care Homes Using Nobi Smart Lights
An independent NHS evaluation across seven Suffolk care homes using Nobi Smart Lights reported up to a 75% reduction in falls‑related hospital admissions and up to a 65% drop in ambulance call‑outs. The study compared six months of baseline data...
Why It’s Critical to Close Open Steps in Cell Therapy Manufacturing
Cell therapy manufacturing is vulnerable to contamination because living cells cannot be terminally sterilized. Regulatory bodies such as EU GMP Annex 1 and the FDA now require risk‑based contamination control strategies that prioritize closed, sterile, and automated processes. Closing open steps...
Sanofi Receives CHMP Recommendation for Dupixent Expansion in Europe
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending Dupixent (dupilumab) for paediatric chronic spontaneous urticaria (CSU) in children aged 2‑11. The recommendation is based on robust Phase III data from the LIBERTY‑CUPID...
FDA Grants PMA to Synergy’s Cervical Disc
Synergy Spine Solutions received FDA pre‑market approval for its Synergy Disc, a cervical artificial disc designed to preserve motion and correct spinal alignment. Clinical data showed an 87.1% composite success rate at 24 months, with significantly lower neck‑pain and arm‑pain...
Opus Genetics Reports Phase I/II Trial Results of OPGx-BEST1 Gene Therapy
Opus Genetics presented early Phase I/II data for its OPGx‑BEST1 gene therapy targeting best vitelliform macular dystrophy and autosomal‑recessive bestrophinopathy. In a sentinel 63‑year‑old participant, the treatment was well tolerated and delivered a 12‑letter gain in best‑corrected visual acuity after...
BioMarin Receives FDA Approval for Palynziq Use in Adolescents
BioMarin’s enzyme substitution therapy Palynziq received FDA approval for use in adolescents aged 12 and older with phenylketonuria (PKU). The decision was based on Phase III PEGASUS trial results showing 44.4% of participants lowered blood phenylalanine below guideline levels, with a...
18 UK Biotech Companies You Should Know About
The article profiles 18 UK biotech firms spanning oncology, immunology, regenerative medicine and AI‑driven drug design, highlighting recent milestones such as Amphista’s $30 million upfront deal with BMS, Autolus’ FDA and EU approvals for obe‑cel, and Isomorphic Labs’ $600 million raise to...
Kardi AI Is Scaling, MDR Class IIa Certified and Series A Ready
Kardi Ai, a Czech med‑tech firm, has secured EU MDR Class IIa certification and is expanding its long‑term ECG monitoring platform into the DACH region. The solution records heart rhythm for up to 12 months, uses AI to deliver physician‑ready reports within...
Interview: The Enduring Appeal of Alternative Medicine
Lewis A. Grossman's book "Choose Your Medicine" traced historic battles over alternative‑medicine freedom, a pattern echoed today as Health Secretary Robert F. Kennedy Jr. pushes to loosen FDA oversight of unapproved stem‑cell and peptide treatments. The interview highlights recurring public resistance...
Monolithic 3D Nanoelectrode Arrays on CMOS Circuitry for Scalable, High‐Resolution Neural Recording
Researchers have developed a monolithic 3D nanoelectrode array (HD‑NEA) that integrates 26,400 vertical nanowire electrodes directly onto commercial CMOS chips. The low‑temperature wafer‑scale post‑fabrication process maintains circuit functionality while delivering uniform, high‑yield electrode performance across 4‑inch wafers. In vitro recordings...
X4 Pharmaceuticals’ Xolremdi (Mavorixafor) Receives the CHMP Positive Opinion for WHIM Syndrome
X4 Pharmaceuticals’ Xolremdi (mavorixafor) received a positive opinion from the European CHMP, recommending approval under exceptional circumstances with an EC decision expected in Q2 2026. The recommendation is based on the global Phase III 4WHIM trial involving 31 patients aged 12 and...
Ipsen Reports the CHMP Positive Opinion for Ojemda (Tovorafenib) for R/R BRAF-Altered Pediatric Low-Grade Glioma (pLGG)
European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending conditional approval of Ipsen’s Ojemda (tovorafenib) as monotherapy for pediatric low‑grade glioma with BRAF fusions, rearrangements or V600 mutations. The recommendation is based on...
Carriers See Higher Claims Severity Amid Medical, Social Inflation and Growth in AI‑Generated Fraud
North American insurers are confronting a surge in claim severity as medical inflation, social inflation, and AI‑generated fraud drive costs upward. The Gallagher Bassett 2026 Carrier Report shows 64% of carriers see more complex claims, with 56% pinpointing rising medical expenses...
The Mental Health Crisis Is Changing — Here’s What Insurers Need to Know
Life‑science firms face heightened D&O liability as stock volatility spikes around clinical trial readouts and regulatory decisions. Shareholder lawsuits often begin with books‑and‑records demands that probe whether public statements matched internal knowledge. The article stresses disciplined, consistent disclosure and early...
AI in Healthcare Revenue Cycle Management: Moving From Automation to Prediction
Healthcare revenue cycle leaders are shifting from rule‑based automation to AI‑driven predictive analytics. Machine‑learning models now scan claim data, documentation and payer behavior to flag denial risks before submission. Early corrections improve first‑pass acceptance, shorten cash cycles and reduce revenue...
Quanterix Corp (QTRX) Q4 2025 Earnings Call Transcript
Quanterix (QTRX) reported FY 2025 revenue of $16.1 million, down $11 million from the prior year, driven by steep declines in collaboration and contract‑manufacturing income. R&D spending fell modestly to $140.7 million, while SG&A rose to $65.5 million due to higher professional fees for...
Cerus Corp (CERS) Q4 2025 Earnings Call Transcript
Cerus Corp reported record total revenue of $233.8 million in 2025, a 16% increase year‑over‑year, driven by strong product sales and robust growth in EMEA. Product revenue rose 14% for both the quarter and full year, with IFC kit sales...
Combining Neurobiological Markers and a Sociodemographic Risk Score to Predict Adolescent Depression – An IDEA RiSCo Prospective Cohort Study
Researchers integrated inflammatory cytokines, kynurenine pathway balance, and amygdala reactivity with the IDEA‑RS sociodemographic risk score to predict adolescent depression over three years. The composite model (IDEA‑BIO‑RS) raised predictive accuracy from a 0.715 AUC to 0.889, correctly classifying 82.2% of...
Xeris Biopharma Holdings Inc (XERS) Q4 2025 Earnings Call Transcript
Xeris Biopharma reported record Q3 2025 product revenue of $74.1 million, a 40% year‑over‑year increase driven primarily by Recorlev’s 109% revenue jump. The company posted its first quarterly net income and an adjusted EBITDA of $17.4 million, reflecting strong operating leverage and...
A Crowdsourced Megastudy of 12 Digital Single-Session Interventions for Depression in US Adults
The researchers conducted a crowdsourced megastudy that tested 12 digital single‑session interventions (SSIs) for depression among a large U.S. adult sample recruited online. Using a preregistered design, three of the SSIs produced statistically significant reductions in depressive symptoms, with effect...
Uniqure NV (QURE) Q4 2025 Earnings Call Transcript
UniQure reported a regulatory setback as the FDA now deems the Phase 1/2 external‑control data for AMT‑130 insufficient for a Biologics License Application, creating uncertainty around the U.S. filing timeline. Despite this, the high‑dose AMT‑130 achieved a statistically significant 75% slowdown...
Urogen Pharma Ltd (URGN) Q4 2025 Earnings Call Transcript
UroGen Pharma reported over $127 million in cash at the end of Q4 2025, affirming sufficient liquidity to reach profitability if current plans hold. The company highlighted steady month‑over‑month growth in Zasturi enrollment, with community treatment share now around 35‑40% and institutional...
Senseonics Holdings Inc (SENS) Q4 2025 Earnings Call Transcript
Senseonics reported a 60% jump in full‑year revenue to $35.3 million and lifted gross margins above 50% after a year of selling the Eversense 365 implantable CGM. The company completed a full transition of commercial operations from Ascensia, eliminating revenue‑sharing and gaining...
Surgery Partners Inc (SGRY) Q4 2025 Earnings Call Transcript
Surgery Partners reported Q4 2025 net revenue of $821.5 million, a 6.6% year‑over‑year increase, and adjusted EBITDA of $136.4 million, up 6.1% with a 16.6% margin. The company revised full‑year revenue guidance to $3.275‑$3.30 billion and adjusted EBITDA to $535‑$540 million, citing delayed capital...
Japan's Hospitals Expand Foreign Patient Care
Japan’s healthcare system is rapidly expanding multilingual services as inbound tourism surges, with 2,500 hospitals and clinics now listed as foreign‑patient friendly—a 1.6‑fold rise over six years. The Hakuba International Clinic exemplifies the trend, handling 40‑50 walk‑ins daily, 80% of...
Why Compliance Failures Are Costing MedTech Manufacturers Millions
Compliance failures are now costing MedTech manufacturers millions, as regulators require deeper traceability, faster reporting, and unified post‑market oversight. Gaps in ERP and QMS integration lead to delayed approvals, recalls, and costly litigation, turning compliance into a direct revenue driver....
Survey Indicates Preferences for Needle-Free Epinephrine Options
A cross‑sectional survey of 210 anaphylaxis patients and caregivers revealed that 90% prefer needle‑free epinephrine delivery, while 89% value devices that are small and easy to carry. Respondents also expressed strong concerns about temperature effects on epinephrine stability. The study...
GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs
GoodRx introduced GoodRx Employer Direct, a new service allowing employers to directly subsidize the manufacturer‑sponsored price of high‑cost brand medications such as GLP‑1 drugs without adding them to health‑plan formularies. The model, first piloted with retailer Hy‑Vee, lets employers contribute...
Among Jesse Jackson’s Key Legacies Was Raising Awareness Around HIV/AIDS
Reverend Jesse Jackson, who died last month, is remembered not only as a civil‑rights icon but also as an early champion of HIV/AIDS awareness. In the 1980s he publicly tested for HIV, urging Black clergy and marginalized communities to confront...
Consumer Price Index Isn’t Properly Accounting For Healthcare Costs
The U.S. Bureau of Labor Statistics’ Consumer Price Index (CPI) omits key out‑of‑pocket healthcare expenses, masking true inflation for many Americans. While the CPI shows a modest 3% rise since President Trump’s second inauguration, premiums on the ACA marketplace have...
Why Telehealth Skills Belong at the Core of Clinical Education
Telehealth is moving from an optional service to a routine component of clinical practice, forcing health‑care educators to rethink curricula. The 2024 U.S. Department of Health and Human Services Workforce Research Recap highlights soaring telehealth utilization and a skills gap...
Letters to the Editor: Post-SSRI Sexual Dysfunction: Challenges and Treatment Approaches
Selective serotonin reuptake inhibitors revolutionized mood‑disorder treatment but often cause sexual side effects. A subset of patients experiences post‑SSRI sexual dysfunction (PSSD), where libido loss, erectile problems and orgasmic difficulties persist months or years after discontinuation. The underlying neurochemical mechanisms...
Letters to the Editor: Responding to Correspondence on “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study”
The authors respond to critiques of their correlational study linking burnout and ethical awareness among mental‑health professionals in Lahore, Pakistan. They acknowledge the purposive, non‑probability sampling limits generalizability but argue it was necessary given fragmented service delivery. Findings showed age...
Exploring Anticholinergic Burden in a Psychiatric Inpatient Population
A retrospective study of 250 psychiatric inpatients measured anticholinergic toxicity scores (ATS) at two seasonal points, finding an average total ATS of eight. Approximately 75% of patients in both winter and spring cohorts exceeded the clinically significant threshold of five,...
Gut Microbiota as a Therapeutic Target for Chronic Pain Disorders
The article reviews emerging evidence that gut microbiota modulation could treat chronic pain disorders such as fibromyalgia, IBS, and temporomandibular joint disease. It links central neurobiological changes—reduced medial prefrontal white matter and altered default‑mode network connectivity—to dopaminergic dysfunction. Dysbiosis, especially...
Member Spotlight: Anna Aslanian on Finding the Right Therapist and Building a Strong Therapeutic Relationship
GoodTherapy’s Member Spotlight features licensed therapist Anna Aslanian, who emphasizes the importance of matching clients with therapists who specialize in their specific concerns. She advises first‑timers to prioritize expertise and personal comfort, noting that a strong therapeutic bond is essential...
Redefining Healthcare Supply Chain Performance, From Spend Control to Strategic Value
Healthcare supply chains are evolving from back‑office cost centers to strategic assets that influence operating rooms, pharmacies, and executive decision‑making. Hospitals now align supply metrics with labor and revenue data, exposing cross‑functional savings that were previously siloed. Objective analytics and...
‘Dementia Village’ in Wisconsin Will House Patients in ‘Main Street USA’ Setting
Agrace Hospice is developing a $40 million, six‑acre Dementia Village in Madison, Wisconsin, modeled after the Dutch Hogeweyk community. The project will feature eight one‑level homes, each housing eight residents, plus a day‑club for 40‑50 non‑resident participants and on‑site housing for...
The Strategic Consolidation of Patient Engagement: Assessing the Viability of the Third Party Portal Market Amidst the Expansion of the...
The NHS is consolidating patient engagement by expanding the NHS App as a national digital front door, aiming for 95% of appointment bookings by 2028 and targeting £11 million in annual savings from phasing out third‑party patient portals. The Wayfinder programme...
Smartphone Photos May Be Misleading Doctors and Putting Patients at Risk: New Research
Remote consultations now rely heavily on patient‑generated smartphone photos, but new research shows that automatic image processing and compression often distort clinically relevant details. Color shifts, loss of fine texture, and lighting inconsistencies can cause doctors to miss or misinterpret...
SNL’s Will Forte On How Huntington’s Disease Has Become A Family Issue
Actor Will Forte, famed for SNL’s “MacGruber,” is leading the “Honestly HD” campaign with Teva Pharmaceuticals to spotlight Huntington’s disease, a progressive neurodegenerative disorder that affects roughly 41,000 Americans. The effort is personal, sparked by his brother‑in‑law Doug Modling’s diagnosis...
One-Question Screen May Flag Hoarding in Alzheimer's and Other Dementias
Researchers at the University of Colorado Anschutz introduced a one‑question screening tool, the Single‑Item Hoarding Screen (SIHS), to detect hoarding behaviors in patients with Alzheimer’s disease and other dementias. In a study of 135 clinic patients, 23 % of caregivers reported...
Humana Offers Scholarships for Xavier Ochsner College of Medicine to Boost Physician Workforce
Humana has launched a $3 million endowment to provide full‑tuition scholarships for incoming students at Xavier Ochsner College of Medicine (XOCOM). The fund targets high‑achieving candidates facing financial hardship and requires recipients to practice in Louisiana, focusing on primary care, internal...
Alabama Hospital Price Transparency: Only 54% Offer A Cost Calculator
A recent study of all 106 non‑psychiatric hospitals in Alabama found that while every facility technically complies with the CMS Hospital Price Transparency rule, only 54 % provide a user‑friendly online cost calculator. More than half of the calculators demand personal...
Mont. Hospital System Brings 24/7 Ambulance Service to Rural County
Intermountain Health will begin providing 24/7 emergency medical services to eastern Yellowstone County, Montana, starting July 1. The partnership with Yellowstone County and the Worden and Shepherd fire districts includes purchasing two ambulances and hiring ten paramedics and EMTs. It addresses...
In China, Phase 2 Study of Relma-Cel in R/R MCL Finds Durable Responses
A phase‑2 trial of relmacabtagene autoleucel (relma‑cel), a CD19‑directed CAR‑T therapy, enrolled 59 Chinese patients with relapsed/refractory mantle‑cell lymphoma after BTK‑inhibitor failure. The study reported a 71.2% overall response rate and a 59.3% complete response rate, with median time to...
Environmental Factors Affect Community Participation Among Individuals With MS
A mixed‑methods study of 505 people with multiple sclerosis (MS) found that personal factors dominate community‑participation outcomes, but environmental factors still contributed an additional 11 % to satisfaction and GPS‑tracked activity. Financial resources, social support and neighborhood safety were linked to...
Pregnancy Biomarkers Reveal Long-Term Cardiovascular Risk in Women
A Danish registry‑linked cohort linked pregnancy biobanking with long‑term health records, showing that third‑trimester high‑sensitivity cardiac troponin I (hs‑cTnI) and soluble fms‑like tyrosine kinase‑1 (sFlt‑1) independently predict maternal cardiovascular disease (CVD) over a median 12‑year follow‑up. Adding week‑29 sFlt‑1 to...